The Society for Melanoma Research (SMR) has announced its 15th International Congress will come to Manchester Central next year.
The conference, to be held 24-28 October 2018, will gather in the UK for the first time. Previous host cities have included Amsterdam, Sapporo, Boston, Zurich, and Brisbane.
The SMR is a diverse, all-volunteer group of scientists working to find the mechanisms responsible for melanoma and, consequently, new therapies for the cancer.
Manchester’s successful bid was supported by the Christie, the Cancer Research UK Manchester Institute, the University of Manchester, Marketing Manchester and Manchester Central. The city was also cited as an example of collaborative working between clinical and basic research.
Professor Paul Lorigan, leading melanoma oncologist from the Christie, said: “We’re very much looking forward to welcoming the SMR’s annual congress to Manchester next year. It comes as recognition not only of the important work the Christie does in the field of melanoma research, but of also of the global significance of Manchester’s wider scientific community.”
Sheona Southern (pictured), MD of Marketing Manchester, said: “It’s a great accolade for Manchester to be chosen as the first ever UK city to host the SMR’s International Congress, particularly as it’s in recognition of our reputation for collaborative work.
“Manchester has a proud history of fostering innovation in healthcare and life sciences, and thanks to our world leading research facilities we’re able to keep attracting great minds to the city for congresses such as these.”